Ex-Vivo Limbal Stem Cell Transplant

Ex-Vivo Limbal Stem Cell Transplantation is a regenerative eye surgery used to restore the damaged corneal surface in patients with Limbal Stem Cell Deficiency (LSCD)

FDA Approved

Advanced Technology

At a Glance

Quick facts about Ex-Vivo Limbal Stem Cell Transplantation.

Ex-Vivo Limbal Stem Cell Transplantation is a regenerative procedure in which a small biopsy of healthy limbal tissue is taken, stem cells are expanded in a laboratory (ex-vivo), and the cultivated cells are transplanted onto the damaged corneal surface.

 Flexible finance up to 24 months interest-free available (via partner finance).

Choose Centre for Sight for its long-established reputation in specialist corneal and ocular surface care, where experienced consultant surgeons use evidence-based techniques and advanced technology to deliver safe, trusted, and consistently high-quality outcomes.

London, Surrey, Sussex

Key Benefits

What Is Limbal Stem Cell Deficiency (LSCD)?

Limbal Stem Cell Deficiency (LSCD) is a serious ocular surface disorder that occurs when the limbal stem cells—located at the junction between the cornea and the sclera—are damaged or depleted. These stem cells are essential for continuously regenerating the corneal epithelium and maintaining a clear, smooth, and stable corneal surface. When they fail, the cornea cannot repair itself properly, leading to persistent epithelial defects, inflammation, ingrowth of conjunctival tissue and blood vessels (corneal neovascularisation), scarring, pain, light sensitivity, and progressive visual loss. LSCD may affect one or both eyes and can result from chemical injuries, inflammatory diseases, infections, contact lens–related damage, or previous ocular surgery. Early diagnosis and specialist management are critical to preserving vision and restoring ocular surface health.

What Are The Treatment Options for Limbal Stem Cell Deficiency?

1

Mild or Partial LSCD

In early or partial cases, treatment focuses on improving ocular surface stability and reducing inflammation. This typically includes preservative-free lubricants to maintain surface hydration, anti-inflammatory eye drops to control surface inflammation, autologous serum tears to promote epithelial healing, and bandage contact lenses to protect the cornea and support regeneration.

2

Severe or Total LSCD

In advanced cases where the limbal stem cell population is significantly reduced or absent, surgical intervention is often required. Treatment options include amniotic membrane transplantation to support healing and reduce inflammation, conjunctival limbal autograft (CLAU) using tissue from a healthy fellow eye, simple limbal epithelial transplantation (SLET), ex-vivo limbal stem cell transplantation (CLET) where stem cells are expanded in the laboratory before transplantation, and allogeneic limbal stem cell transplantation using donor tissue when both eyes are affected. The choice of procedure depends on disease severity, laterality, and overall ocular surface health.

What Are the Benefits of Stem Cell?

Ex-vivo limbal stem cell transplantation offers a regenerative approach to restoring the damaged ocular surface in patients with limbal stem cell deficiency. By expanding healthy limbal stem cells in a controlled laboratory environment before transplantation, this technique helps rebuild a stable, self-renewing corneal epithelium while minimising risk to the donor tissue. The procedure is designed to improve comfort, reduce inflammation, and enhance visual potential, particularly in complex or severe cases where conventional treatments are insufficient.

Frame 35 2

Benefits (vary by procedure):

Restoration of the corneal surface

Ex vivo stem cell transplantation aims to restore the limbal stem cell population responsible for maintaining a healthy corneal surface, helping the eye regenerate normal epithelial tissue.

Improved vision and ocular comfort

By rebuilding the damaged ocular surface, the procedure may reduce pain, irritation and light sensitivity while improving visual clarity in suitable patients.

Treatment for severe ocular surface disease

This procedure may offer a treatment option for conditions such as limbal stem cell deficiency caused by chemical injury, inflammatory disease, infection or previous surgery.

Regenerative treatment approach

The technique uses laboratory-expanded stem cells to rebuild the surface of the eye, supporting long-term healing and stability of the cornea.

Frame 35 3

Risks/side effects (not exhaustive):

Failure of stem cell graft integration

In some cases, the transplanted stem cells may not successfully integrate or survive on the ocular surface.

Infection or inflammation

As with any eye surgery, there is a small risk of infection or inflammation during the healing process.

As with any eye surgery, there is a small risk of infection or inflammation during the healing process.

The underlying condition affecting the cornea may recur or continue to affect the eye after treatment.

Need for additional treatments

Some patients may require further procedures or ongoing medical therapy to maintain ocular surface health.

Gradual visual recovery

Vision improvements may develop gradually as the corneal surface regenerates and stabilises.

Not Sure If You're Eligible?

Book a comprehensive eye examination to better understand your vision and available treatment options.

Who is Suitable for Stem Cell?

Your consultant will carefully assess your eyes to determine whether ex vivo stem cell transplantation is the most appropriate treatment for your condition. Suitability depends on the cause and severity of damage to the ocular surface, as well as the overall health of your eyes.

Frame 35 4

You may be a suitable candidate if you:

Have limbal stem cell deficiency (LSCD)

This condition occurs when the stem cells responsible for maintaining the corneal surface are damaged or depleted, leading to persistent irritation, scarring and vision problems.

Have severe ocular surface damage

The procedure may be recommended for patients with damage caused by chemical injury, trauma, infection, inflammatory disease or previous eye surgery.

Have persistent symptoms that have not responded to conventional treatments

When standard treatments such as lubricating drops, medications or contact lenses are no longer effective, stem cell transplantation may be considered.

Have a stable underlying eye condition

Successful treatment often requires that inflammation or active disease affecting the eye is well controlled before surgery.

Frame 35 5

Some factors may affect suitability for ex vivo stem cell transplantation, including severe damage to other structures of the eye, uncontrolled inflammation, active infection, or significant retinal disease that limits visual potential.

 

A detailed consultation at Centre for Sight will allow your specialist to examine your eyes, review your medical history and determine whether ex vivo stem cell transplantation or another ocular surface treatment is the most appropriate option for you.

Flexible Financing Options

Private Medical Insurance

Many of our consultants work with all of the major insurance providers*

Self Pay

Pay in full for patients who prefer a straightforward approach

0% APR Financing

6-24 month payment plans with approved credit 

Military Discount

5% discount for active military and veterans

 

* Private Medical Insurance is unlikely to cover Laser Eye Surgery procedures, Implantable Contact Lenses or Laser Lens Replacement

Stem Cell Information

Below are some of the most frequently asked questions about stem cell transplantation

Only those with problems involving the eye surface in particular those patients who have Limbal stem cell deficiency. These include those who have had chemical (acid or alkaline), thermal injuries or Stevens Johnsons Syndrome, which have resulted in damage to the limbus. There are also a group of patients who have congenital deficiency of stem cells, including those with Aniridia and ectodermal dysplasia. Who cannot be treated by ex-vivo stem cell transplantation? Eye problems that do not involve the eye surface and cornea.   Examples of conditions that CANNOT be treated include: Age related macular degeneration Retinitis pigmentosa Glaucoma Optic neuritis and other problems of the optic nerve Severe eye injuries involving the retina (back of the eye) Keratoconus Fuchs corneal dystrophy

The transplant can provide long-term surface stability, but outcomes depend on the underlying disease and control of inflammation.

Most patients experience mild discomfort during recovery, which is managed with medication.

Our stem cells for transplantation are taken from a donor eye. The Limbal stem cells from this eye are cultivated into a new sheet of cells, which are then transplanted on to the eye.

A full fact sheet can be found on Stem Cell Treatment.

Have Questions?

Our patient care team is here to answer any questions you may have.

Patient Success Stories

Videos

About Centre for Sight

Sky News - Sight Saving Stem Cell Treatment

Certifications & Recognition

The Power List 2026

Global Top 50: Mr. Sheraz Daya

Top 1% Surgeons

National recognition

CQC Accredited

Highest safety standards

5-Star Rated

Patient satisfaction